{"id":"nandrolone","rwe":[{"pmid":"41731719","year":"2026","title":"Lean mass loss in the intensive care unit and its restoration: A narrative review.","finding":"","journal":"Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition","studyType":"Clinical Study"},{"pmid":"41616897","year":"2026","title":"N-acetyl-cysteine alleviates nandrolone decanoate-induced hippocampal cell apoptosis in rats via reversing protein expressions of S1P1, Akt and FOXO3a signaling pathway.","finding":"","journal":"Steroids","studyType":"Clinical Study"},{"pmid":"41505445","year":"2026","title":"Combined nandrolone and resistance training induced cardiac remodelling and oxidative stress despite enhanced cardiomyocyte contractility.","finding":"","journal":"PloS one","studyType":"Clinical Study"},{"pmid":"41477377","year":"2025","title":"Nandrolone Decanoate for Postmenopausal Osteoporosis: A Systematic Review and Meta-Analysis of Randomized Trials.","finding":"","journal":"Cureus","studyType":"Clinical Study"},{"pmid":"41401039","year":"2025","title":"Impact Of Caloric Intake In Cancer Cachexic Patients On Nandrolone - A Prospective Observational Study.","finding":"","journal":"International journal of pharmaceutical compounding","studyType":"Clinical Study"}],"tags":[{"label":"Androgen","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Sex hormone-binding globulin","category":"target"},{"label":"SHBG","category":"gene"},{"label":"SERPINA6","category":"gene"},{"label":"SLC22A1","category":"gene"},{"label":"A14AB01","category":"atc"},{"label":"Off-Patent","category":"patent"},{"label":"Generic Available","category":"availability"},{"label":"Active","category":"status"},{"label":"Anemia of chronic renal failure","category":"indication"},{"label":"Anabolic Agents","category":"pharmacology"},{"label":"Androgens","category":"pharmacology"},{"label":"Hormones","category":"pharmacology"}],"phase":"marketed","safety":{"drugInteractions":[{"url":"/drug/ciclosporin","drug":"ciclosporin","action":"Monitor closely","effect":"May interact with Cyclosporine","source":"DrugCentral","drugSlug":"ciclosporin"}],"commonSideEffects":[{"effect":"Testicular atrophy","drugRate":"","severity":"common","organSystem":""},{"effect":"Oligospermia","drugRate":"","severity":"common","organSystem":""},{"effect":"Inhibition of testicular function","drugRate":"","severity":"common","organSystem":""},{"effect":"Gynecomastia","drugRate":"","severity":"common","organSystem":""},{"effect":"Acne","drugRate":"","severity":"common","organSystem":""},{"effect":"Edema","drugRate":"","severity":"common","organSystem":""},{"effect":"Nausea","drugRate":"","severity":"common","organSystem":""},{"effect":"Vomiting","drugRate":"","severity":"common","organSystem":""},{"effect":"Diarrhea","drugRate":"","severity":"common","organSystem":""},{"effect":"Hirsutism","drugRate":"","severity":"common","organSystem":""},{"effect":"Male pattern baldness in women","drugRate":"","severity":"common","organSystem":""},{"effect":"Clitoral enlargement","drugRate":"","severity":"common","organSystem":""},{"effect":"Menstrual irregularities","drugRate":"","severity":"common","organSystem":""},{"effect":"Deepening of voice in women","drugRate":"","severity":"common","organSystem":""},{"effect":"Insomnia","drugRate":"","severity":"common","organSystem":""},{"effect":"Depression","drugRate":"","severity":"common","organSystem":""},{"effect":"Excitation","drugRate":"","severity":"common","organSystem":""},{"effect":"Habituation","drugRate":"","severity":"common","organSystem":""},{"effect":"Impotence","drugRate":"","severity":"common","organSystem":""},{"effect":"Phallic enlargement","drugRate":"","severity":"common","organSystem":""}],"contraindications":["Benign prostatic hyperplasia","Body fluid retention","Breast Carcinoma in Males","Breastfeeding (mother)","Decompensated cardiac failure","Diabetes mellitus","Disease of liver","Disorder of coronary artery","Heart disease","Humoral hypercalcemia of malignancy","Hypercalcemia","Hypercholesterolemia","Myocardial infarction","Neoplasm of prostate","Nephrotic syndrome","Obstruction of bile duct","Pregnancy, function","Renal failure syndrome"],"seriousAdverseEvents":[{"effect":"Hepatocellular neoplasms","drugRate":"","severity":"serious"},{"effect":"Peliosis hepatis","drugRate":"","severity":"serious"},{"effect":"Chronic priapism","drugRate":"","severity":"serious"},{"effect":"Premature closure of epiphyses in children","drugRate":"","severity":"serious"},{"effect":"Decreased glucose tolerance","drugRate":"","severity":"serious"},{"effect":"Bleeding in patients on concomitant anticoagulant therapy","drugRate":"","severity":"serious"}]},"trials":[],"aliases":[],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=NANDROLONE","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T03:01:22.440839+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T03:01:29.543387+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=NANDROLONE","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T03:01:30.166454+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: Androgen Receptor agonist","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T03:01:30.717635+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200946/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T03:01:30.619426+00:00"}},"allNames":"nandrolon","offLabel":[],"synonyms":["nandrolone","menidrabol","nandrolon","norandrostenolon","norandrostenolone","nortestonate","nortestosterone","oestrenolon","19-Nortestosterone"],"timeline":[{"date":"2010-08-30","type":"neutral","source":"FDA Orange Book","milestone":"Generic entry — 4 manufacturers approved"}],"approvals":[],"brandName":"Nandrolon","ecosystem":[{"indication":"Anemia of chronic renal failure","otherDrugs":[],"globalPrevalence":null}],"mechanism":{"target":"Sex hormone-binding globulin","targets":[{"gene":"SHBG","source":"DrugCentral","target":"Sex hormone-binding globulin","protein":"Sex hormone-binding globulin"},{"gene":"SERPINA6","source":"DrugCentral","target":"Corticosteroid-binding globulin","protein":"Corticosteroid-binding globulin"},{"gene":"SLC22A1","source":"DrugCentral","target":"Solute carrier family 22 member 1","protein":"Solute carrier family 22 member 1"},{"gene":"AR","source":"DrugCentral","target":"Androgen receptor","protein":"Androgen receptor"}],"modality":"Small Molecule","drugClass":"Androgen","explanation":"","oneSentence":"","technicalDetail":"Nandrolone exerts its effects by binding to androgen receptors, which then activate the transcription of genes involved in erythropoiesis, the process of red blood cell production."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/1879","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=NANDROLONE","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=NANDROLONE","fields":["publications"],"source":"PubMed/NCBI"},{"id":4,"url":"https://www.fda.gov/drugs/drug-approvals-and-databases/orange-book-data-files","fields":["patents","exclusivity","genericManufacturers"],"source":"FDA Orange Book"}],"_enrichedAt":"2026-03-30T12:53:59.637400","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T03:01:32.475360+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"ethylestrenol","drugSlug":"ethylestrenol","fdaApproval":"1964-05-28","patentStatus":"Unknown","relationship":"same-class"}],"genericName":"nandrolone","indications":{"approved":[{"name":"Anemia of chronic renal failure","source":"DrugCentral","snomedId":49708008,"regulator":"FDA"}],"offLabel":[{"name":"Congenital hypoplastic anemia","source":"DrugCentral","drugName":"NANDROLONE","evidenceCount":1,"evidenceLevel":"emerging"},{"name":"Hb SS disease","source":"DrugCentral","drugName":"NANDROLONE","evidenceCount":2,"evidenceLevel":"emerging"}],"pipeline":[]},"currentOwner":"Woodward Specl","drugCategory":"active","labelChanges":[],"patentStatus":"Off-patent — no active Orange Book patents","relatedDrugs":[{"drugId":"ethylestrenol","brandName":"ethylestrenol","genericName":"ethylestrenol","approvalYear":"1964","relationship":"same-class"}],"trialDetails":[{"nctId":"NCT02754687","phase":"PHASE1","title":"Single Dose, Dose-Ranging Study of 11-β Methyl Nortestosterone Dodecylcarbonate (11β-MNTDC) in Healthy Men","status":"COMPLETED","sponsor":"Premier Research","startDate":"2016-07-14","conditions":["Healthy Men","Male Contraception"],"enrollment":12,"completionDate":"2017-06-05"},{"nctId":"NCT06462482","phase":"PHASE4","title":"Peri-Operative Testosterone Administration in Primary Hip Arthroscopy","status":"NOT_YET_RECRUITING","sponsor":"American Hip Institute","startDate":"2025-01","conditions":["Femoro Acetabular Impingement"],"enrollment":60,"completionDate":"2026-12"},{"nctId":"NCT06608914","phase":"PHASE4","title":"Peri-Operative Testosterone Administration in Primary Total Hip Arthroplasty","status":"NOT_YET_RECRUITING","sponsor":"American Hip Institute","startDate":"2025-01","conditions":["Osteoarthritis, Hip"],"enrollment":60,"completionDate":"2026-12"},{"nctId":"NCT05978206","phase":"PHASE2","title":"Study of the Effectiveness of Treatment of Sarcopenia With the Use of a Medicinal Product (Nandrolone), Comprehensive Physiotherapy and Diet","status":"RECRUITING","sponsor":"National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland","startDate":"2023-08-10","conditions":["Sarcopenia"],"enrollment":168,"completionDate":"2026-10-30"},{"nctId":"NCT02055456","phase":"PHASE1,PHASE2","title":"Nandrolone Decanoate in the Treatment of Telomeropathies","status":"COMPLETED","sponsor":"University of Sao Paulo","startDate":"2014-02-01","conditions":["Aplastic Anemia","Bone Marrow Failure Syndromes","Idiopathic Pulmonary Fibrosis","Telomere Shortening"],"enrollment":20,"completionDate":"2017-02-01"},{"nctId":"NCT00673309","phase":"PHASE2,PHASE3","title":"Assessment of Mechanisms of Improved Wound Healing","status":"COMPLETED","sponsor":"The University of Texas Medical Branch, Galveston","startDate":"2000-07","conditions":["Burns"],"enrollment":644,"completionDate":"2013-04"},{"nctId":"NCT05805553","phase":"NA","title":"Anabolic Steroid and Propranolol in Paediatric Burn","status":"UNKNOWN","sponsor":"King Edward Medical University","startDate":"2020-12-01","conditions":["Arrest","Bone","Development","Growth"],"enrollment":114,"completionDate":"2023-09-28"},{"nctId":"NCT03142035","phase":"NA","title":"Dienogest Versus GnRH-a Pre-treatment in Women With Endometriosis Undergoing IVF","status":"UNKNOWN","sponsor":"American University of Beirut Medical Center","startDate":"2017-10-22","conditions":["Endometriosis"],"enrollment":189,"completionDate":"2023-02-22"},{"nctId":"NCT00000854","phase":"PHASE1","title":"A Study to Evaluate the Effect of Nandrolone Decanoate in Women With HIV-Associated Weight Loss","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":["HIV Infections","HIV Wasting Syndrome"],"enrollment":38,"completionDate":"2003-05"},{"nctId":"NCT03545347","phase":"PHASE2","title":"Physiotherapy, Nutritional Supplement and Anabolic Steroids in Rehabilitation of Patients With Hip Fracture.","status":"COMPLETED","sponsor":"Morten Tange Kristensen PT, PhD","startDate":"2018-09-03","conditions":["Hip Fractures"],"enrollment":29,"completionDate":"2020-06-03"},{"nctId":"NCT00675714","phase":"PHASE2,PHASE3","title":"Assessment of the Treatment of Severely Burned With Anabolic Agents on Clinical Outcomes, Recovery and Rehabilitation","status":"TERMINATED","sponsor":"The University of Texas Medical Branch, Galveston","startDate":"2004-01","conditions":["Burns"],"enrollment":1126,"completionDate":"2019-07-15"},{"nctId":"NCT03298373","phase":"PHASE1","title":"28-Day Repeat-Dose, Dose Escalation Study of 11-β Methyl Nortestosterone Dodecylcarbonate (11β-MNTDC) in Healthy Men","status":"UNKNOWN","sponsor":"Premier Research","startDate":"2017-11-09","conditions":["Healthy Men","Male Contraception"],"enrollment":43,"completionDate":"2020-02-05"},{"nctId":"NCT03263520","phase":"NA","title":"Impact of the Use of Nandrolone on the Treatment of Malnutrition Induced by Cancer","status":"COMPLETED","sponsor":"Hospital Erasto Gaertner","startDate":"2016-02","conditions":["Cachexia; Cancer"],"enrollment":60,"completionDate":"2017-10-31"},{"nctId":"NCT02376309","phase":"NA","title":"The Effect of Nandrolone Decanoate and Leucine on Muscle Loss","status":"COMPLETED","sponsor":"Maastricht University Medical Center","startDate":"2015-08","conditions":["Muscle Atrophy"],"enrollment":30,"completionDate":"2017-08"},{"nctId":"NCT00812630","phase":"PHASE1","title":"A Two-part Trial Assessing the Effects of 7α-methyl-19-nortestosterone (MENT) on Blood Pressure in Normal Men: an Open-label Pilot Study Followed by a Randomized, Double-blind, Placebo-controlled Study","status":"COMPLETED","sponsor":"Population Council","startDate":"2008-12","conditions":["Blood Pressure"],"enrollment":68,"completionDate":"2014-03"},{"nctId":"NCT00000597","phase":"PHASE3","title":"Multi-Center Trial of Anti-Thymocyte Globulin in Treatment of Aplastic Anemia and Other Hematologic Disorders","status":"COMPLETED","sponsor":"National Heart, Lung, and Blood Institute (NHLBI)","startDate":"1982-03","conditions":["Anemia, Aplastic","Hematologic Diseases","Pancytopenia","Blood Disease"],"enrollment":0,"completionDate":"1988-12"},{"nctId":"NCT00242463","phase":"PHASE2","title":"Anabolic Steroids for Nutritional Rehabilitation of Critically Ill Patients","status":"TERMINATED","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2005-10","conditions":["Malnutrition","Critical Illness"],"enrollment":20,"completionDate":"2007-10"},{"nctId":"NCT00250536","phase":"NA","title":"Anabolic Steroids and Exercise in Hemodialysis Patients","status":"COMPLETED","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2000-03","conditions":["End-Stage Renal Disease","Muscle Weakness"],"enrollment":80,"completionDate":"2004-10"},{"nctId":"NCT00682123","phase":"PHASE1,PHASE2","title":"Risk of Positive Doping Tests Following Ingestion of Supplements Contaminated With Trace Quantities of Nandrolone Metabolites","status":"COMPLETED","sponsor":"Loughborough University","startDate":"2006-03","conditions":["Positive Doping Tests in Sports"],"enrollment":20,"completionDate":"2006-09"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"_patentsChecked":true,"crossReferences":{"NUI":"N0000147940","MMSL":"2095","NDDF":"001259","UNII":"6PG9VR430D","VUID":"4019854","CHEBI":"CHEBI:7466","VANDF":"4019854","INN_ID":"295","RXNORM":"7244","UMLSCUI":"C0027368","chemblId":"CHEMBL1200946","ChEMBL_ID":"CHEMBL2104906","KEGG_DRUG":"D08250","DRUGBANK_ID":"DB13169","PDB_CHEM_ID":" 6VW","PUBCHEM_CID":"9904","SNOMEDCT_US":"126171003","IUPHAR_LIGAND_ID":"6949","MESH_DESCRIPTOR_UI":"D009277"},"formularyStatus":[],"_enricherVersion":"v2","_offLabelChecked":true,"developmentCodes":[],"ownershipHistory":[{"period":"present","companyName":"Woodward Specl","relationship":"Current Owner"}],"pharmacokinetics":{"source":"DrugCentral","bioavailability":"2%"},"publicationCount":1360,"therapeuticAreas":["Hematology"],"atcClassification":{"source":"DrugCentral","atcCode":"A14AB01","allCodes":["A14AB01","S01XA11"]},"biosimilarFilings":[],"recentPublications":[{"date":"2026 Apr","pmid":"41731719","title":"Lean mass loss in the intensive care unit and its restoration: A narrative review.","journal":"Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition"},{"date":"2026 Apr","pmid":"41616897","title":"N-acetyl-cysteine alleviates nandrolone decanoate-induced hippocampal cell apoptosis in rats via reversing protein expressions of S1P1, Akt and FOXO3a signaling pathway.","journal":"Steroids"},{"date":"2026","pmid":"41505445","title":"Combined nandrolone and resistance training induced cardiac remodelling and oxidative stress despite enhanced cardiomyocyte contractility.","journal":"PloS one"},{"date":"2025 Nov","pmid":"41477377","title":"Nandrolone Decanoate for Postmenopausal Osteoporosis: A Systematic Review and Meta-Analysis of Randomized Trials.","journal":"Cureus"},{"date":"2025 Nov-Dec","pmid":"41401039","title":"Impact Of Caloric Intake In Cancer Cachexic Patients On Nandrolone - A Prospective Observational Study.","journal":"International journal of pharmaceutical compounding"}],"companionDiagnostics":[],"genericManufacturers":4,"_genericFilersChecked":true,"genericManufacturerList":["Abraxis Pharm","Am Regent","Epic Pharma Llc","Watson Labs"],"status":"active","companyName":"Woodward Specl","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T03:01:32.475360+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"verified","dataCompleteness":{"mechanism":false,"indications":true,"safety":true,"trials":true,"score":3}}